CU Boulder team advances HPV vaccine research

Soligenix, a late-stage biopharmaceutical company that develops products addressing unmet medical needs in the areas of oncology, inflammation and biodefense, recently collaborated with research doctors at the University of Colorado (CU Boulder) to demonstrate the ability of a heat stable vaccine formulation of a human papillomavirus (HPV) vaccine. Read More »

Study reviews stability of RNA within Ebola virus

Emerging Infectious Disease Journal recently featured a series of articles about Ebola and studies related to it, including a look at the stability of RNA within the Ebola virus using urine samples and EDTA blood samples taken from people infected with the virus. Read More »

NIH introduces improved tools for HIV treatment

The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), recently began an initiative to further develop long-lasting treatments and prevention for HIV infections. Read More »

Sanofi Pasteur focuses on antigens with broader protection abilities

Creating new antigens is a central theme in the Sanofi Pasteur strategy, according to Harry Kleanthous, the company’s associate vice president for research. Read More »

University of Rochester tests novel method for HIV prevention

Researchers at New York's University of Rochester Medical Center recently began testing a new approach to preventing HIV infections. Read More »

Mass drug administration credited with stopping malaria in Greece

A mass drug administration (MDA) program has been credited with preventing malaria from spreading throughout Greece, which experienced a resurgence in 2011. Read More »

South Korea provides update on MERS-CoV

Health professionals in South Korea have reported that there have not been any evolutionary rate changes in Middle East respiratory syndrome coronavirus (MERS-CoV) throughout the 2015 MERS outbreak. Read More »

BYU engineers develop more efficient vaccine-production method

Chemical engineers from Brigham Young University have found a way to accelerate the development and production process for creating vaccines designed to protect people from new viruses. Read More »

AIDS research journal explores PrEP prevention methods

AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert Inc., recently featured articles about the use of emerging biomedical pre-exposure prophylaxis (PrEP) to prevent HIV infections. Read More »

FDA approves first in-human study of MERS vaccine

A new Middle East Respiratory Syndrome (MERS) vaccine developed by GeneOne Life Science Inc. and Inovio Pharmaceuticals has received approval from the Food and Drug Administration to begin its first in-human clinical study. Read More »

US continues to support TB prevention in India

Officials from India and the United States, which has funded approximately $100 million in prevention and control measures against tuberculosis (TB) in the Asian nation, recently noted more than 15 million people have received vaccines over the last 18 years. Read More »

Sri Lanka continues fight against dengue fever

Officials at the Health Ministry in Sri Lanka's Western Province of Colombo recorded 750 dengue fever cases in October. Read More »

Company commits to help Nigeria with diarrhea and malaria prevention

Consumer health and hygiene company Reckitt Benckiser (RB) recently committed itself to helping Nigeria with its prevention efforts against diarrhea and malaria. Read More »

Fear of HIV testing leaves millions unaware of condition

Researchers from Royal Holloway at the University of London have conducted the biggest worldwide review of the psychological barriers that stop people from receiving HIV testing. Read More »

WHO holds global influenza vaccine conference

The World Health Organization (WHO) and The Hong Kong Polytechnic University (PolyU) held a worldwide meeting Nov. 18-20 in Geneva titled “The fourth WHO Informal Consultation for Improving Influenza Vaccine Virus Selection.” Read More »

Brain scan shows cognitive deficits in HIV patients

Neuroscientists from the Georgetown University Medical Center recently conducted a study that uses brain scans to show the cognitive deficits found in older adults who have HIV infections. Read More »

Gamma interferon protects mice from Ebola virus

University of Iowa scientists recently used gamma interferon, a drug approved by the U.S. Food and Drug Administration, to protect mice from the Ebola virus. Read More »

Mexico approves Flublok vaccine

Protein Sciences Corp., the producer of Flublok, recently received approval from Mexico to distribute the company’s Flublok influenza vaccine to the Mexican market. Read More »

University of Maryland's Ebola vaccine declared safe and effective

A recent clinical trial shows that a new Ebola vaccine (ChAd3-EBO-Z) provokes a strong immune response and has positive toleration in adults living in Mali and in the U.S. Read More »

Antiretroviral drug protects breastfeeding babies from HIV-infected mothers

BodyScientists recently conducted a study in four nations located in Africa to determine that administering a liquid antiretroviral drug treatment to breastfeeding babies effectively protects the children from contracting HIV infections from mothers who have HIV. Read More »